HAND2 and GPM6A methylation in ctDNA may be powerful, non-invasive markers for early colorectal cancer detection and ...

Cardiac biomarkers may not only be indicative of cardiac events, but could also be predictive of future cancer diagnosis, ...

Cuproptosis represents a novel mechanism of cell death characterized by intracellular copper ion accumulation.

Recent research highlights that structured exercise is a powerful tool for reducing the risk of colorectal cancer. ...

The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader ...

Only a third of patients with advanced cancer had molecular testing to help guide the use of targeted therapies, a review of ...

RNA-based liquid biopsy developed at the University of Chicago detects early-stage colorectal cancer with 95% accuracy using ...

Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and ...

Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...

Miscellaneous 15.07.2025 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal ...